461 related articles for article (PubMed ID: 25452213)
41. Specific stabilization of promoter G-Quadruplex DNA by 2,6-disubstituted amidoanthracene-9,10-dione based dimeric distamycin analogues and their selective cancer cell cytotoxicity.
Roy S; Ali A; Kamra M; Muniyappa K; Bhattacharya S
Eur J Med Chem; 2020 Jun; 195():112202. PubMed ID: 32302880
[TBL] [Abstract][Full Text] [Related]
42. Chelerythrine down regulates expression of VEGFA, BCL2 and KRAS by arresting G-Quadruplex structures at their promoter regions.
Jana J; Mondal S; Bhattacharjee P; Sengupta P; Roychowdhury T; Saha P; Kundu P; Chatterjee S
Sci Rep; 2017 Jan; 7():40706. PubMed ID: 28102286
[TBL] [Abstract][Full Text] [Related]
43. Bisaryldiketene derivatives: A new class of selective ligands for c-myc G-quadruplex DNA.
Peng D; Tan JH; Chen SB; Ou TM; Gu LQ; Huang ZS
Bioorg Med Chem; 2010 Dec; 18(23):8235-42. PubMed ID: 21036049
[TBL] [Abstract][Full Text] [Related]
44. Spectroscopic studies of Thioflavin-T binding to c-Myc G-quadruplex DNA.
Verma S; Ghuge SA; Ravichandiran V; Ranjan N
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Apr; 212():388-395. PubMed ID: 30703662
[TBL] [Abstract][Full Text] [Related]
45. Design, synthesis and biological evaluation of 4-anilinoquinazoline derivatives as new c-myc G-quadruplex ligands.
Jiang Y; Chen AC; Kuang GT; Wang SK; Ou TM; Tan JH; Li D; Huang ZS
Eur J Med Chem; 2016 Oct; 122():264-279. PubMed ID: 27372288
[TBL] [Abstract][Full Text] [Related]
46. Discovery of Novel 11-Triazole Substituted Benzofuro[3,2-b]quinolone Derivatives as c-myc G-Quadruplex Specific Stabilizers via Click Chemistry.
Zeng DY; Kuang GT; Wang SK; Peng W; Lin SL; Zhang Q; Su XX; Hu MH; Wang H; Tan JH; Huang ZS; Gu LQ; Ou TM
J Med Chem; 2017 Jul; 60(13):5407-5423. PubMed ID: 28514170
[TBL] [Abstract][Full Text] [Related]
47. c-MYC G-quadruplex binding by the RNA polymerase I inhibitor BMH-21 and analogues revealed by a combined NMR and biochemical Approach.
Musso L; Mazzini S; Rossini A; Castagnoli L; Scaglioni L; Artali R; Di Nicola M; Zunino F; Dallavalle S
Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):615-629. PubMed ID: 29229300
[TBL] [Abstract][Full Text] [Related]
48. Selective recognition of c-MYC G-quadruplex DNA using prolinamide derivatives.
Chauhan A; Paladhi S; Debnath M; Dash J
Org Biomol Chem; 2016 Jun; 14(24):5761-7. PubMed ID: 26963597
[TBL] [Abstract][Full Text] [Related]
49. Stabilization of VEGF G-quadruplex and inhibition of angiogenesis by quindoline derivatives.
Wu Y; Zan LP; Wang XD; Lu YJ; Ou TM; Lin J; Huang ZS; Gu LQ
Biochim Biophys Acta; 2014 Sep; 1840(9):2970-7. PubMed ID: 24931695
[TBL] [Abstract][Full Text] [Related]
50. Studies on non-covalent interaction of coumarin attached pyrimidine and 1-methyl indole 1,2,3 triazole analogues with intermolecular telomeric G-quadruplex DNA using ESI-MS and spectroscopy.
Raju G; Srinivas R; Reddy MD; Reddy ChR; Nagesh N
Nucleosides Nucleotides Nucleic Acids; 2014; 33(7):489-506. PubMed ID: 24972013
[TBL] [Abstract][Full Text] [Related]
51. A newly identified G-quadruplex as a potential target regulating Bcl-2 expression.
Sun H; Xiang J; Shi Y; Yang Q; Guan A; Li Q; Yu L; Shang Q; Zhang H; Tang Y; Xu G
Biochim Biophys Acta; 2014 Oct; 1840(10):3052-7. PubMed ID: 25086254
[TBL] [Abstract][Full Text] [Related]
52. KRAS oncogene repression in colon cancer cell lines by G-quadruplex binding indolo[3,2-c]quinolines.
Lavrado J; Brito H; Borralho PM; Ohnmacht SA; Kim NS; Leitão C; Pisco S; Gunaratnam M; Rodrigues CM; Moreira R; Neidle S; Paulo A
Sci Rep; 2015 Apr; 5():9696. PubMed ID: 25853628
[TBL] [Abstract][Full Text] [Related]
53. Discovery of a New Four-Leaf Clover-Like Ligand as a Potent c-MYC Transcription Inhibitor Specifically Targeting the Promoter G-Quadruplex.
Hu MH; Wang YQ; Yu ZY; Hu LN; Ou TM; Chen SB; Huang ZS; Tan JH
J Med Chem; 2018 Mar; 61(6):2447-2459. PubMed ID: 29474069
[TBL] [Abstract][Full Text] [Related]
54. Discovery of Novel Schizocommunin Derivatives as Telomeric G-Quadruplex Ligands That Trigger Telomere Dysfunction and the Deoxyribonucleic Acid (DNA) Damage Response.
Che T; Chen SB; Tu JL; Wang B; Wang YQ; Zhang Y; Wang J; Wang ZQ; Zhang ZP; Ou TM; Zhao Y; Tan JH; Huang ZS
J Med Chem; 2018 Apr; 61(8):3436-3453. PubMed ID: 29618208
[TBL] [Abstract][Full Text] [Related]
55. Exploration of binding affinity and selectivity of brucine with G-quadruplex in the c-myb proto-oncogene by electrospray ionization mass spectrometry.
Li H; Hai J; Zhou J; Yuan G
Rapid Commun Mass Spectrom; 2016 Feb; 30(3):407-14. PubMed ID: 26754134
[TBL] [Abstract][Full Text] [Related]
56. Structure of the biologically relevant G-quadruplex in the c-MYC promoter.
Yang D; Hurley LH
Nucleosides Nucleotides Nucleic Acids; 2006; 25(8):951-68. PubMed ID: 16901825
[TBL] [Abstract][Full Text] [Related]
57. Wild-type p53 binds to MYC promoter G-quadruplex.
Petr M; Helma R; Polášková A; Krejčí A; Dvořáková Z; Kejnovská I; Navrátilová L; Adámik M; Vorlíčková M; Brázdová M
Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27634752
[TBL] [Abstract][Full Text] [Related]
58. Syntheses and evaluation of acridone-naphthalimide derivatives for regulating oncogene PDGFR-β expression.
Zhang M; Wei Z; Gong X; Li X; Kang S; Wang J; Liu B; Huang ZS; Li D
Bioorg Med Chem; 2021 Mar; 34():116042. PubMed ID: 33561716
[TBL] [Abstract][Full Text] [Related]
59. Identification of a new class of WNT1 inhibitor: Cancer cells migration, G-quadruplex stabilization and target validation.
Chang LC; Chen TC; Chen SJ; Chen CL; Lee CC; Wu SH; Yen Y; Huang HS; Lin JJ
Oncotarget; 2016 Oct; 7(42):67986-68001. PubMed ID: 27626678
[TBL] [Abstract][Full Text] [Related]
60. Anti-cancer activity of benzoxazinone derivatives via targeting c-Myc G-quadruplex structure.
Jiang S; Awadasseid A; Narva S; Cao S; Tanaka Y; Wu Y; Fu W; Zhao X; Wei C; Zhang W
Life Sci; 2020 Oct; 258():118252. PubMed ID: 32791149
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
